The complex series of events that is required to establish unique, cell type-specific geneexpression programmes is truly amazing. One just has to take a step back and remember that the information encoded in DNA is the same in all cell types, yet the reading and processing of this information is specific to individual cells as well as to the response of those cells to changing environmental conditions. There are many layers of control that must be precisely coordinated to establish developmentally appropriate gene-expression patterns, and even small alterations can have severe consequences on the fate of the cell [1] [2] [3] [4] . This is powerfully illustrated by the plethora of human diseases that can be traced back to mutations in transcriptional regulatory proteins [5] [6] [7] . This complexity can be daunting for the researchers who are trying to understand cellular differentiation unless mechanistic questions are first broken apart into smaller, discrete problems. It is imperative to begin somewhere, and a common starting point is defining the complement of transcription factors that are required for a unique cell fate decision. In common terminology, this first step is determining the 'master regulators' for a cell fate. The simplified paradigm of the master regulator relies on the premise that each developmental cell type is defined by a critical transcription factor. This means that there is a transcription factor that is both required and sufficient for programming an individual cell fate. Another aspect of this paradigm is that the master regulator is expressed in a restricted expression pattern, which means that in a particular developmental lineage, it is only found in cells of a specific fate. Finally, to be classified as a master regulator, these transcription factors need to come from families that are important in different developmental contexts, and mutations in these proteins often cause developmental defects.
In this Opinion article, we briefly examine how the 'master regulator' terminology has shaped our thought process in relation to CD4 + T cell subset differentiation. Specifically, thinking of the key lineage-specifying transcription factors for specialized CD4 + T cell subtypes in terms of the master regulator paradigm caused the impression that the expression of a single master regulator transcription factor unilaterally created absolute and stable CD4 + T cell subtypes.
However, recent studies have instead demonstrated that the co-expression of lineagespecifying transcription factors in CD4 + T cell subsets actually creates the flexibility and diversity of CD4 + T cell phenotypes. The current state of the field now suggests that the simplistic paradigm of a single master regulator transcription factor that applies to stable developmental decisions, such as T-helperinducing POZ/Krüppel-like factor (ThPOK; also known as ZBTB7B) committing cells to the CD4 + instead of the CD8 + T cell lineage 8 , may not so neatly apply to the more flexible differentiation pathways of specialized CD4 + T cell subtypes.
Defining the 'master regulators'
In the CD4 + T cell differentiation field, a substantial effort was put into identifying the critical transcription factors that are required for the differentiation of each helper T cell fate. For instance, the T-box transcription factor T-bet (also known as TBX21) was identified as the factor that is required and sufficient to induce the T helper 1 (T H 1)-type gene-expression programme 9, 10 . Early studies also found that T-bet expression was restricted to T H 1 cells when examining canonical helper T cell differentiation conditions in vitro or when examining immune responses to pathogens that induce strong T H 1-type polarizing conditions in vivo [9] [10] [11] . Additionally, T-bet is a member of the T-box transcription factor family, which is required for many developmental cell fate decisions 12 . Taken together, these data led to the identification of T-bet as the 'master regulator' transcription factor for T H 1 cell differentiation 9 . Similar research efforts defined the transcription factors GATA-binding protein 3 (GATA3), retinoic acid receptorrelated orphan receptor-γt (RORγt), B cell lymphoma 6 (BCL-6) and forkhead box P3 (FOXP3) as 'master regulators' for T H 2, T H 17, T follicular helper (T FH ) and regulatory T (T Reg ) cells, respectively [13] [14] [15] [16] [17] [18] [19] . These collective groundbreaking studies contributed to our early understanding of CD4 + T cell responses and created a basis to form new hypotheses to predict the immune responses that occur when environmental conditions promote the expression of each of these transcription factors. Abstract | There is an emerging body of research demonstrating that the co-expression of key lineage-specifying transcription factors, commonly referred to as 'master regulators', affects the functional capabilities and flexibility of CD4 + T cell subsets. Here, we discuss how the natural co-expression of these lineage-specifying transcription factors has challenged the concept that the expression of a single 'master regulator' strictly establishes an absolute CD4 + T cell phenotype. Instead, it is becoming clear that the interplay between the lineage-specifying (or lineage-defining) transcription factors, including T-bet, GATA3, RORγt, BCL-6 and FOXP3, contributes to the fate and flexibility of CD4 + T cell subtypes. This in turn has led to the realization that CD4 + T cell phenotypes are more diverse than previously recognized.
Beyond the 'master regulator' paradigm Although it was important to start with identifying the crucial lineage-specifying transcription factors required for the differentiation of specialized CD4 + T cell subtypes, the term 'master regulator' may have unintentionally created the impression that helper T cell differentiation is dependent upon an absolute hierarchy of control that results in a preordained phenotype
. Reflecting this thought process, perhaps the most common assumption that comes to mind with the terminology 'master regulator' is that expression equals phenotype. For example, the expression of T-bet in CD4 + T cells has been equated with a canonical T H 1 cell phenotype, whereas the expression of BCL-6 would equal a canonical T FH cell phenotype 9, [16] [17] [18] . The biggest pitfall of this underlying assumption can be unintentionally missing the complexity of the CD4 + T cell response by focusing on the expression of only one transcription factor. Notably, it is becoming apparent that the expression of a single 'master regulator' transcription factor is not sufficient to define the phenotype of a CD4 + T cell subtype; instead, it is the context of its expression that is critical [20] [21] [22] . Nowhere is this concept more apparent than in the emerging data in the field demonstrating that the lineage-specifying transcription factors that define CD4 + T cell subsets are actually co-expressed in many circumstances and, in fact, it is the interplay between these factors that determines the final outcome of the gene-expression profile (and phenotype) of CD4 + T cells. Importantly, this phenomenon has been observed with the co-expression of T-bet and GATA3, RORγt or BCL-6 in CD4 + T cells, as well as with FOXP3 and T-bet, signal transducer and activator of transcription 3 (STAT3), GATA3, RORγt or BCL-6 in specialized T Reg cells, as discussed below [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] .
Transient versus stable co-expression
Many of the early studies that first reported the co-expression of lineage-specifying transcription factors in CD4 + T cells described a transient co-expression of these key factors during the early stages of the commitment of CD4 + T cells into specialized subtypes. In these circumstances, co-expression creates a scenario in which environmental signals can tip the balance of expression in favour of one factor or another (FIG. 1) . This allows the signals generated from the innate immune response to a pathogen to select one factor, pushing the CD4 + T cell down the 'winning' factor's commitment pathway. Studies demonstrating that a competition between T-bet and GATA3 occurs as CD4 + T cells begin to commit towards the T H 1 or T H 2 lineage were consistent with the idea that the transient co-expression of these factors can play a competitive and antagonistic part in the lineage-commitment process 26 . Studies examining FOXP3 and RORγt also supported the concept that initial CD4 + T cell subtype commitment decisions are affected by the balance between two lineage-specifying transcription factors 34, 35 . These early observations were still consistent with a 'master regulator' transcription factor having the role of an absolute determinant for CD4 + T cell subset fate because their co-expression was transient, creating a competitive environment that would be quickly resolved by external cues generated by innate immune cells. However, studies by many independent laboratories examining CD4 + T cell differentiation both in vitro and in vivo have shown stable co-expression of the helper T cell lineage-specifying transcription factors in committed CD4 + T cell subset populations 24, 25, [27] [28] [29] [30] 33, 36, 37 . These studies have also revealed more complexity in the gene-expression programmes and phenotypes of CD4 + T cells than previously appreciated, with current data suggesting that changing environmental conditions can alter the underlying potential of CD4 + T cell subtypes and allow for flexibility or plasticity in their responses 38 . Taken together, these studies have now raised the question of how the stable co-expression of lineagespecifying transcription factors affects the gene-expression programme and phenotype of CD4 + T cells.
Specialized T Reg cell populations
A well-recognized example demonstrating a functional role for the stable co-expression of two seemingly opposing lineage-specifying transcription factors can be found in specialized T Reg cell populations 39, 40 . Here, the simultaneous expression of FOXP3 with T-bet, GATA3, STAT3 or BCL-6 has been linked to the ability of T Reg cells to suppress T H 1, T H 2, T H 17 or T FH cell responses, respectively 23, 24, 27, 28, 33 . The current data in the field have clearly shown that the simultaneous expression of both FOXP3 and an additional helper T cell lineage-specifying transcription factor is necessary for T Reg cells to functionally control specialized immune responses. An intriguing aspect of this example is that one of the lineage-specifying transcription factors, FOXP3, is dominant in creating the inherent properties of the cell. That is, the gene-expression profile of the cell is still predominantly characterized by the FOXP3-dependent induction of a T Reg cell gene-expression programme, with the stable co-expression of the additional lineage-specifying factor subtly shifting the homing properties of the T Reg cell 24, 27, 28 . Thus, although a somewhat hybrid geneexpression programme representing the combined activities of FOXP3 and the additional lineage-specifying factor is created, the FOXP3-dependent regulatory programme dominates the functional characteristics of the cell. Ongoing research is actively defining the mechanisms by which FOXP3 establishes these hybrid gene-expression profiles
. Interestingly, a recent study using a proteomics approach to this topic suggests that at least some of the hybrid nature of the T Reg cell gene programme may be mediated by the physical interactions between FOXP3 and a subset of helper T cell lineage-specifying factors 41 .
Box 1 | An unintended consequence of the 'master regulator' terminology
One unanticipated side effect of the 'master regulator' terminology has been that the importance of other crucial transcription factor families has at times been subtly diminished in the field. For instance, although T-bet is commonly termed the master regulator for T helper 1 (T H 1) cell development, the T H 1 gene-expression programme also requires a number of other transcriptional regulatory proteins, most notably signal transducer and activator of transcription 1 (STAT1) and STAT4 . In reality, the parts that STAT1 and STAT4 play in establishing a T H 1 cell-associated gene-expression programme are of equal importance to the role of T-bet. Associated with this same point, many more ubiquitously expressed proteins also have essential roles in helper T cell differentiation, and we have yet to fully appreciate their significance in many settings [60] [61] [62] [63] . Sometimes these other transcriptional regulators are lost in our focus on the role of the 'master regulator' of a cell lineage. Together with our new recognition that the co-expression of lineage-specifying transcription factors creates a greater diversity of CD4 + T cell phenotypes than previously recognized, we also need to be sure to incorporate the complexity derived from additional required regulatory factors operating in these cells. With the expanding capabilities in genomics and proteomic experimental approaches becoming increasingly available to researchers, perhaps now an achievable goal may be a detailed analysis that integrates the networks of transcriptional regulatory proteins that are required to create the diversity of CD4 'T H 2+1': GATA3 and T-bet co-expression It has long been established that T-bet and GATA3 are transiently co-expressed in naive helper T cells before the initial lineage subtype commitment decision 26 . Recently, the issue of T-bet and GATA3 co-expression became more complex and now can no longer be completely explained within the context of a simple master regulator paradigm. In the setting of a normal immune response, cells that were previously defined as being 'T H 2 cells' on the basis of their stable expression of GATA3 were found to upregulate T-bet in response to lymphocytic choriomeningitis virus (LCMV) infection 25 . This caused the cell to express a hybrid gene-expression programme with characteristics of both T H 1 and T H 2 cells. These cells were named 'T H 2+1' to reflect this phenomenon, and they represent one of the first examples of how the natural co-expression of two opposing helper T cell lineage-specifying transcription factors during the course of an immune response can change the functional capabilities of helper T cells. These data also suggest that helper T cells do not fit neatly into strictly defined end-point lineages, but rather remain responsive to changing environmental conditions.
T H 17 cell diversity and pathogenicity
The co-expression of T-bet and RORγt in helper T cell subpopulations clearly illustrates the problem of strictly interpreting the expression of T-bet or RORγt from the perspective of the master regulator paradigm. Shortly after the identification of RORγt as the 'master regulator' for T H 17 cells, studies began to emerge demonstrating that interleukin-17-positive and interferon-γ-positive (IL-17 + IFNγ + ) helper T cell populations exist that stably express both T-bet and RORγt 36, 42, 43 . Whether helper T cells differentiating along the T H 17 pathway express RORγt alone, or rather RORγt in combination with T-bet, appears to be determined by the nature of the pathogen and the cytokine environment. Studies have shown that RORγt and T-bet co-expression in 'T H 17' cells is promoted by the absence of transforming growth factor-β1 (TGFβ1), or a shift in the cytokine environment in favour of TGFβ3 (REFS 36, 44, 45) . The co-expression of T-bet and RORγt creates a hybrid 'T H 17' gene programme that can control certain pathogens such as Candida albicans but, importantly, this programme also has a propensity to become pathogenic and cause autoimmune states 36, 44, 45 . Therefore, the co-expression of T-bet and RORγt provides a compelling example of the consequences for the natural co-expression of helper T cell lineage-specifying transcription factors in defining complex, and potentially pathogenic, helper T cell phenotypes.
Flexibility in T H 1 and T FH programmes
Another example for the stable co-expression of two opposing helper T cell lineagespecifying transcription factors is that of T-bet and BCL-6 in CD4 + T cells. Both in vivo and in vitro studies have shown that variable levels of BCL-6 can be expressed + T cell phenotypes. In naive CD4 + T cells, crucial lineagespecifying transcription factors are expressed at low levels and are kept in an equal balance. Signals from innate immune cells tip the scales in favour of the expression of one factor over the other. In the paradigm of the master regulator, the scales are tipped in an 'all-or-none' fashion, with the expression of one master regulator increasing, while the expression of the opposing master regulator will be extinguished (left side). However, new research demonstrating that lineage-specifying transcription factors are co-expressed, creating diverse CD4 + T cell phenotypes, has changed our concept of this simple paradigm (right side). In this new model, termed 'lineage-specifying' (or 'lineage-defining'), the co-expression of the lineage-specifying transcription factors can tip the scales to variable levels, causing intermediate phenotypes (Xʹ and Yʹ) in addition to the phenotypes that were previously viewed as end-point lineages (X and Y). Additionally, as the balance of co-expression changes in response to environmental signals, this can create flexibility or plasticity between the intermediate phenotypes.
Nature Reviews | Immunology . The current data suggest that the balance between T-bet and BCL-6 co-expression is functionally important in determining the phenotype of the helper T cell and its role in the immune response. For example, in effector T H 1 cells with high T-bet expression, BCL-6 is also expressed at low levels 29, 30, 37 , and this is essential for the T-bet-dependent repression of T H 2 cell-associated genes 29 . Interestingly, the balance between T-bet and BCL-6 can be shifted in favour of BCL-6 either by reducing the strength of IL-2 signalling or upregulating inducible T cell co-stimulator (ICOS)-ICOS ligand interactions 30, 37, 48, 49 . Tipping the balance towards an increased ratio of BCL-6 to T-bet alters the gene-expression profile of the CD4 + T cell and, depending on the level of BCL-6, creates the potential for T central memory (T CM ) cell-or T FH cell-like gene expression characteristics 30, 37 . When examining this phenomenon from the perspective of T H 1 or T FH cell differentiation, a balance between BCL-6 and T-bet is also observed, with STAT4 having a role in regulating both BCL-6 and T-bet expression 46, 47 . Here, a transitional state with dual T FH cell-like and T H 1 cell-like characteristics occurs until the balance favours either BCL-6 or T-bet. Notably, epigenetic profiling studies indicate that the loci for Bcl6, Tbx21 (the gene that encodes T-bet) and Prdm1 (the gene that encodes B lymphocyteinduced maturation protein 1 (BLIMP1)) are maintained in poised epigenetic states so they will remain responsive to changing environ mental conditions 46, 50 . Collectively, the studies performed to date suggest that the co-expression of T-bet and BCL-6 creates a scenario that allows helper T cells in the T H 1 and T FH subtypes to remain responsive to environmental conditions and express diverse gene-expression programmes that include more states than merely end-point T H 1 or T FH cell phenotypes (FIG. 1) .
Mechanisms that regulate co-expression
With the realization that the natural co-expression of helper T cell lineagespecifying transcription factors is important for defining the functional potential and flexibility of CD4 + T cells, a new area of research emphasis is determining the mechanisms by which these factors regulate each other's activities 51 . Studies are underway characterizing how the lineage-specifying transcription factors functionally interact with each other in different settings to create the gene-expression programme of the CD4 + T cell subsets 23, 30, 47 . One important question to address is whether these factors
Box 2 | Molecular mechanisms that define specialized T Reg cell subsets
Even though the co-expression of forkhead box P3 (FOXP3) and an additional lineage-specifying transcription factor is required to create specialized regulatory T (T Reg ) cell suppressor programmes, a number of mechanistic studies have also suggested that additional regulatory proteins have crucial roles in this process. This concept is clearly illustrated by recent studies examining type 1 diabetes and arthritis in FOXP3 -green fluorescent protein (GFP) transgenic mice on different susceptibility backgrounds 65, 66 . These studies found that the fusion of GFP to the amino-terminal domain of FOXP3 creates a hypomorphic protein that impairs, or in one case enhances, proteinprotein interactions that occur within the N-terminal domain of FOXP3. Specifically, this alters the ability of FOXP3 to interact with regulatory proteins such as interferon regulatory factor 4 (IRF4), hypoxia-inducible factor 1α (HIF1α) and chromatin-modifying complexes. Functionally, the extra-thymic generated (induced) T Reg cells that were derived in this setting had the ability to control arthritis, but were unable to control type 1 diabetes. These data suggest that proteinprotein interactions mediated through the N-terminal domain of FOXP3 are required to create unique subtypes of functionally specialized T Reg cells. Future research examining how specialized T Reg cell functions are influenced by the co-expression of opposing lineage-specifying transcription factors, as well as by these other regulatory proteins, will be of great interest.
Figure 2 | T-bet-BCL-6 complexes prevent BCL-6 from binding to its target genes. Shown is a schematic representation of how the physical interaction between T-bet and B cell lymphoma 6 (BCL-6) influences the activities of both proteins. T-bet-BCL-6 complexes can bind to T-bet DNAbinding elements, allowing T-bet to target the repressive capabilities of BCL-6 to these T-bet DNA-binding sites. By contrast, the T-bet-BCL-6 complex prevents BCL-6 from associating with its own DNA-binding elements because the complex masks the DNA-binding domain of BCL-6. This means that the balance between T-bet and BCL-6 determines where these two proteins will be functionally targeted within a cell population. Notably, environmental signalling events can regulate their expression levels, changing the balance and creating flexibility within helper T cell populations. ICOS, inducible T cell co-stimulator; IL-2, interleukin-2; T FH , T follicular helper; T H 1, T helper 1. act in a cooperative or antagonistic fashion. That is, are they collaborators, competitors or both depending upon the circumstances? The molecular mechanisms that define the interplay between T-bet and BCL-6 provide one example that illustrates the complexity of this question.
T-bet and BCL-6 functionally control each other's activities in part through their physical interaction and also in part through their ability to cross-regulate each other's expression in some circumstances 17, 18, 29, 30 . Early studies demonstrated that in effector T H 1 cells, a T-bet-BCL-6 complex specifically associates with T-bet DNA-binding elements 29 . Thus, T-bet is able to target BCL-6 in a site-specific manner to repress genes that are important for T H 2 cell development. This observation raised the question of how BCL-6 activity is regulated in T H 1 cells to prevent it from tipping the balance of the cell towards a T FH cell gene-expression programme. The nature of the physical interaction between T-bet and BCL-6 provided insight into this question, with the DNAbinding domain of BCL-6, but not T-bet, being required to mediate the physical interaction between these two proteins 30 . This creates a scenario in which a T-bet-BCL-6 complex masks the DNA-binding domain of BCL-6 while leaving the T-bet DNA-binding domain available. Thus, the molecular mechanisms of this interaction explain why T-bet-BCL-6 complexes are preferentially targeted to T-bet DNA-binding elements and why BCL-6 is prevented from regulating its own gene-expression programme when excess T-bet is available in the cell (FIG. 2) . Studies examining the physical interactions between T-bet and GATA3, as well as FOXP3 and RORγt or GATA3, have also provided unique mechanistic insights 26, 35, 41 . The principles uncovered in all of these studies illustrate how defining the molecular details by which CD4 + T cell subtypespecifying transcription factors influence each other's activities will aid in our ability to predict the outcome for the co-expression of these factors in a given setting.
Summary and perspective
The examples discussed above represent only a few in this emerging area of research, with each highlighting the importance of taking a step back to re-examine our views on the simple paradigm of the master regulator in the differentiation of specialized CD4 + T cell subtypes. One aspect of this paradigm that has held up over time in relation to CD4 + T cell subtype differentiation is that a select group of transcription factors is required to define the prototypic characteristics of CD4 + T cell subsets. However, it is also now apparent that the expression of a single master regulator transcription factor alone is not sufficient to invoke an absolute, end-point phenotype. Perhaps these findings reflect that the differentiation of specialized CD4 + T cell subtypes may not truly represent a stable developmental decision, such as the stable commitment decision to either the CD4 + or CD8 + T cell lineage. Instead, it is now becoming more widely accepted that CD4 + T cell subtypes retain at least some potential to respond to changing environmental conditions by altering their underlying subtype-specific gene programmes. This may be an immunologically important characteristic of CD4 + T cells that allows them to coordinate and fine-tune the immune response in real time.
With this new recognition for the limitations of thinking about specialized CD4 + T cell subtypes through the lens of the master regulator paradigm, a subtle shift in the use of our terminology from 'master regulator' to 'lineage-specifying' or 'lineagedefining' transcription factor is warranted in the CD4 + T cell field. This nomenclature reflects the requirement for these transcription factors in defining CD4 + T cell subtype characteristics, but it de-emphasizes the concept of an 'all-or-nothing' and completely stable phenotype that is dictated by a single transcription factor (FIG. 1) . This will be an especially important concept as the field moves forwards, as it is now clear that the range of CD4 + T cell phenotypes that arise to control specific pathogenic insults is much greater than previously thought [20] [21] [22] . One needs to look no further than the examples discussed here to realize that the context in which the lineage-specifying transcription factors are expressed plays a substantial part in determining the final outcome each has on the gene-expression programme of the cell. Our challenge now becomes understanding this complexity and designing experimental approaches to determine how the co-expression of two or more helper T cell lineagespecifying transcription factors influences gene-expression programmes and how this creates the diversity that is required to establish a productive immune response to control myriads of pathogenic insults.
